DD India
March 20, 2025 3:50 PM
Global pharmaceutical company Eli Lilly has launched Mounjaro (tirzepatide) in India, a groundbreaking drug designed for the treatment of Type 2 diabetes and obesity. Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro is n...
February 19, 2025 4:48 PM
Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss that can increase the risk of falls and decrease overall strength, which coul...
December 2, 2024 4:35 PM
Four oral glucagon-like peptide-1 receptor (GLP-1R) drugs, currently under Phase III trials, are in the race for approval, according to a report. This follows the immense popularity of injectable GLP-1R drugs, such as Novo Nordisk’s Wegovy and Sax...
October 15, 2024 7:33 PM
Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high rate of long-term sickness that has become a major drag on the economy. Health minister Wes Streeting predicted the use of the ...
September 11, 2024 4:40 PM
Novo Nordisk said on Wednesday that its highly anticipated experimental weight-loss pill amycretin was safe and tolerable for patients in an early-stage trial, with mild-to-moderate side effects. The maker of blockbuster drugs Wegovy and Ozempic sai...
August 15, 2024 4:10 PM
Older Americans are having little success getting prescriptions for weight-loss drug Wegovy covered by Medicare despite the federal healthcare program's decision to pay for patients with obesity at risk of heart disease, according to their doctors. ...
August 1, 2024 5:26 PM
Trial results show Eli Lilly's weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure, the company said on Thursday as it continues to build a case for the medicati...
July 31, 2024 7:18 PM
The benefit of Eisai and Biogen's Alzheimer's drug Leqembi in patients with early-stage Alzheimer's appears to increase with continued use with no new safety issues, according to three-year data presented at an Alzheimer's meeting on Tuesday. In the...
July 11, 2024 7:35 PM
Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice- daily version of the drug late last year. The new drug is part of th...
July 9, 2024 4:57 PM
Shares in Novo Nordisk, maker of the wildly popular obesity drug Wegovy were down 1.1% on Tuesday after the publication of a data analysis showing rival Eli Lilly's own treatment Mounjaro leads to faster and greater weight loss. The analysis was pub...
Copyright © 2025 DD India. All rights reserved
Visitors: 4924504
Last updated on: 2nd Apr 2025
